MPLT · MapLight Therapeutics, Inc.

$11.21 -0.02 (-0.18%)

Market Cap

$563.49M

46.38M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher A. Kroeger	President and Chief Executive Officer	$655,250	—	$12,296,267	$12,322,406	$331,000	$19,331	$25,624,254
Erin Pennock Foff	M.D., Ph.D. Chief Medical Officer	$531,000	—	$2,871,478	$2,636,670	$194,000	$20,851	$6,254,000
Vishwas Setia	Chief Financial Officer	$432,294	—	$3,200,500	$2,367,617	$183,000	$19,153	$6,202,564

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher A. Kroeger	President and Chief Executive Officer	$628,000	—	$7,878,380	—	$262,504	$20,258	$8,789,142
Vishwas Setia	Chief Financial Officer	$332,051	—	$2,628,846	—	$99,745	$8,333	$3,068,975
Erin Pennock Foff	M.D., Ph.D. Chief Medical Officer	$509,000	—	$2,065,491	—	$158,660	$19,600	$2,752,751

Executive changes

Person	Role	Change	Effective	Filed
Jonathan Gillis	interim Chief Financial Officer and interim principal financial officer	Appointed	2026-06-18	2026-06-18

Key facts CIK 1770069 CUSIP 56565P103 13F (30d) 106 filings 104 filers Visit website Investor relations